Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Zai Lab Ltd ADR (NQ: ZLAB ) 30.92 +0.03 (+0.10%) Streaming Delayed Price Updated: 4:00 PM EST, Nov 5, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Zai Lab Ltd ADR < Previous 1 2 3 4 5 6 7 8 9 ... 11 12 Next > Spectrum Brands Posts Upbeat Results, Joins AerSale, Sinclair, ICU Medical And Other Big Stocks Moving Higher On Thursday May 09, 2024 Via Benzinga Top 5 Health Care Stocks That Could Sink Your Portfolio In Q2 May 09, 2024 Via Benzinga 12 Health Care Stocks Moving In Thursday's Pre-Market Session May 09, 2024 Via Benzinga Recap: Zai Lab Q4 Earnings February 27, 2024 Via Benzinga Earnings Scheduled For February 27, 2024 February 27, 2024 Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly loss at $0.07 per share on revenue of $100.49 million. Via Benzinga What Happened With Zai Lab Stock? December 21, 2023 Zai Lab Limited (NASDAQ: ZLAB) shares traded lower on Thursday. The stock has pulled back sharply from recent strength. Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday May 09, 2024 Pre-market stock movers are a hot topic this morning and we've got traders covered with all of the news behind these movements on Thursday! Via InvestorPlace ZLAB Stock Earnings: Zai Lab Beats EPS, Beats Revenue for Q1 2024 May 08, 2024 ZLAB stock results show that Zai Lab beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. Via InvestorPlace Zai Lab Announces First Quarter 2024 Financial Results and Recent Corporate Updates May 08, 2024 From Zai Lab Limited Via Business Wire Zai Lab to Announce First Quarter 2024 Financial Results and Recent Corporate Updates on May 8, 2024 April 15, 2024 From Zai Lab Limited Via Business Wire Zai Lab Statement on Executive Management Team’s Agreement on Share Activities April 11, 2024 From Zai Lab Limited Via Business Wire Week In Review: ProfoundBio, A Seattle-Suzhou ADC Biotech, Acquired By Genmab For $1.8 Billion April 06, 2024 ProfoundBio will be acquired by Copenhagen’s Genmab A/S in a $1.8 billion all-cash deal. The acquisition will expand Genmab’s drug portfolio, including three ProfoundBio clinical stage ADC candidates... Via Talk Markets Zai Lab Presentations at AACR 2024 Annual Meeting to Showcase Ongoing Clinical Studies in Key Global Oncology Programs April 02, 2024 From Zai Lab Limited Via Business Wire One Good, One Bad News For Bristol Myers Squibb's Marketed Drugs: Details April 01, 2024 Bristol Myers Squibb shares update on Phase 3 YELLOWSTONE trial for Zeposia (ozanimod) in Crohn's disease. Primary endpoint not met, safety consistent. Also, positive Phase 3 results for Krazati... Via Benzinga Zai Lab Partner Bristol Myers Squibb Announces Pivotal KRYSTAL-12 Confirmatory Trial Evaluating KRAZATI (adagrasib) Meets Primary Endpoint of Progression-Free Survival for Patients with Pretreated KRASG12C-Mutated Locally Advanced or Metastatic... April 01, 2024 From Zai Lab Limited Via Business Wire Zai Lab Partner Novocure Announces METIS Phase 3 Clinical Trial Met Primary Endpoint, Demonstrating a Statistically Significant Extension in Time to Intracranial Progression for Patients with Brain Metastases from Non-Small Cell Lung Cancer March 27, 2024 From Zai Lab Limited Via Business Wire Shhh! 7 Small-Cap Stocks That Can Double by 2025 March 20, 2024 Small-cap stocks have been hot and these shares discussed here are likely to heat up and double over the next year. Via InvestorPlace Stock Disconnect Triggers Investor Exodus From CStone Pharma March 14, 2024 Key Takeaways: CEO Jason Yang has increased his CStone stake multiple times over the past 18 months to 4.79% of outstanding shares, signaling confidence in the company Via Benzinga Zai Lab to Present Data Highlighting ZL-1310, a Novel Antibody-Drug Conjugate (ADC) for Treatment of Solid Tumors March 13, 2024 From Zai Lab Limited Via Business Wire Zai Lab to Present Final Overall Survival (OS) Data from Phase 3 NORA Study of ZEJULA (niraparib) in Platinum-Sensitive Recurrent Ovarian Cancer (PSROC) March 06, 2024 From Zai Lab Limited Via Business Wire Zai Lab Announces Participation in March Investor Conference March 06, 2024 From Zai Lab Limited Via Business Wire Zai Lab Announces Full-Year 2023 Financial Results and Recent Corporate Updates February 27, 2024 From Zai Lab Limited Via Business Wire Top 5 Health Care Stocks That Are Preparing To Pump In February February 09, 2024 The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. Via Benzinga Zai Lab to Announce Full-Year 2023 Financial Results and Recent Corporate Updates on February 27, 2024 January 25, 2024 From Zai Lab Limited Via Business Wire Archer-Daniels-Midland, B. Riley Financial And Other Big Stocks Moving Lower In Monday's Pre-Market Session January 22, 2024 U.S. stock futures were higher this morning, with the Nasdaq futures gaining around 100 points on Monday. Shares of Archer-Daniels-Midland Company (NYSE: ADM) fell sharply in today’s pre-market trading... Via Benzinga Zai Lab Announces The New England Journal of Medicine Publication Demonstrating Durable Clinical Activity of Repotrectinib in Patients with Advanced ROS1 Fusion-Positive NSCLC January 10, 2024 From Zai Lab Limited Via Business Wire Paychex Reports Downbeat Sales, Joins BlackBerry And Other Big Stocks Moving Lower On Thursday December 21, 2023 U.S. stocks traded higher, with the Dow Jones index gaining around 200 points on Thursday. Via Benzinga Topics Stocks Exposures US Equities Zai Lab Announces Participation in January Investor Conference December 19, 2023 From Zai Lab Limited Via Business Wire Paratek Pharmaceuticals Announces Inclusion of Oral NUZYRA® in China’s National Reimbursement Drug List December 13, 2023 From Paratek Pharmaceuticals, Inc. Via GlobeNewswire Zai Lab Announces the First Listing of VYVGART® (efgartigimod alfa injection) and Other Updates in China’s National Reimbursement Drug List December 12, 2023 From Zai Lab Limited Via Business Wire < Previous 1 2 3 4 5 6 7 8 9 ... 11 12 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
